Welcome to our dedicated page for Target SEC filings (Ticker: TGT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Target Corporation filings document formal disclosures for a large U.S. retailer, including earnings releases furnished on Form 8-K, proxy materials, leadership and board changes, and material financing arrangements. Recent event reports cover operating results, financial guidance, executive appointments, compensation arrangements, board committee assignments, and a short-term credit facility.
The company's proxy materials describe director elections, board committee structure, executive compensation, equity awards, pay-versus-performance disclosures, governance practices, and shareholder voting matters. These filings connect Target's retail operations and capital structure with recurring disclosure topics such as liquidity, leverage covenants, executive compensation, and shareholder governance.
TARGET CORP executive Brian C. Cornell reported open-market sales of a total of 50,000 shares of Common Stock on May 27, 2026, executed indirectly through a trust. The trades were recorded at volume-weighted average prices of $130.5459 and $129.8383 per share, with actual prices ranging from $129.45 to $130.61 according to the footnotes.
After these sales, the trust-related line items showed holdings of 193,270 and 194,270 shares, while Cornell also directly owned 133,506 shares and held 495.9387 shares in the Target Corporation 401(k) Plan as of March 31, 2026. A footnote notes that 46,817 of the trust shares were previously reported as directly owned and were transferred to a revocable living trust in which Cornell has a beneficial interest.
Target Corporation submitted a Form 144 notice reporting the proposed sale of 50,000 shares of Common Stock through Pershing Advisor Solutions, with an aggregate value shown as $6,200,000.00. The filing also discloses a sale by Brian Cornell of 50,000 shares on 03/10/2026 for $6,088,020.05.
The record lists 452,855,589 shares on the same row with a date of 05/27/2026 and indicates the security trades on NYSE. The filing lists multiple restricted stock vesting entries with specific grant dates and share counts.
Target Corporation reported stronger-than-expected first quarter 2026 results, with clear signs of a demand recovery. Net sales rose 6.7% to $25.4 billion, driven by 5.6% comparable sales growth as traffic increased 4.4%. Digital comparable sales grew 8.9%, led by more than 27% growth in same-day delivery and nearly 25% growth in non-merchandise revenue such as advertising and memberships.
GAAP and Adjusted diluted EPS were both $1.71. GAAP EPS declined 24.5% from $2.27 a year ago, which included large interchange fee settlement gains, while Adjusted EPS rose 31.6% from $1.30. Gross margin improved to 29.0%, and Adjusted operating margin increased to 4.5%. Management raised 2026 guidance, now targeting net sales growth around 4%, full-year operating margin more than 20 basis points above the 2025 Adjusted level of 4.6%, and GAAP and Adjusted EPS near the high end of the prior $7.50 to $8.50 range.
Target Corporation received an exempt solicitation letter from Trillium Asset Management urging shareholders to vote AGAINST Executive Chair Brian Cornell and Lead Independent Director Christine Leahy at the June 10, 2026 Annual Meeting.
Trillium cites multi-year underperformance versus the S&P 500 Consumer Discretionary Index, recurring declines in net and in-store sales across recent quarters, reputational ranking declines, and governance concerns including the Board’s decision to promote long‑time executive Michael Fiddelke to CEO while retaining Mr. Cornell as Executive Chair and Special Advisor (role described as continuing through March 2027). The letter highlights prior buybacks of $7.4B (2022), $2.8B (2023), and $1.1B (2025), and cites compensation for Mr. Cornell including a $1.12M base salary, a 200% of base 2026 cash incentive target, and $6M in restricted stock units.
Target Corporation faces a shareholder proposal (Item 6) asking the board to report on the presence of pesticides in Target’s private‑label brands and efforts to quantify and reduce them. The proposal, supported by Trillium and several institutional proponents, urges disclosure of pesticide measurement, reduction targets, and supplier verification, citing supply‑chain, regulatory, reputational, and health risks and noting competitors with timebound IPM commitments. The proponents reference Target’s 1 million acres soil‑health goal and argue current disclosures lack quantitative pesticide metrics and supplier baseline assessments. Shareholders are asked to vote FOR Item 6 at the Annual Meeting on June 10, 2026.
Vanguard Capital Management reports beneficial ownership of 34,035,678 shares of Target Corp common stock, representing 7.51% of the class. The filing states Vanguard Capital Management has sole dispositive power over 34,035,678 shares and sole voting power over 4,627,750 shares. The filing lists affiliated investment management entities and is signed by the Head of Global Fund Administration on 04/30/2026.
Target Corporation has issued its 2026 proxy statement for the virtual Annual Meeting on June 10, 2026, outlining key governance and voting matters. Shareholders will vote on electing 12 directors, ratifying Ernst & Young as auditor, an advisory Say on Pay vote, and approving an amended 2020 Long-Term Incentive Plan.
The proxy describes a major leadership transition: Michael J. Fiddelke became CEO on February 1, 2026, while Brian C. Cornell moved to Executive Chair. Christine A. Leahy continues as Lead Independent Director, with clearly defined independent oversight responsibilities.
The Board highlights its governance framework, including annual director elections under a majority voting standard, proxy access (3% for three years), a 10% special meeting threshold, tenure and retirement policies, and fully independent committees. Three long-serving directors will step down at the 2026 meeting, while two new independent directors, Stephen Bratspies and John Hoke III, join the Board, supporting ongoing refreshment and a mix of retail, design, technology, and financial expertise.
Target Corporation Chief Accounting Officer Matthew A. Liegel reported a discretionary transaction involving 3,425.8308 deferred compensation units indexed to Target common stock at a reference value of $116.76 per unit. These units are part of the company’s Executive Deferred Compensation Plan and are economically equivalent to the same number of Target common shares.
After this transaction, Liegel holds 7,134.7280 deferred compensation units tied to Target stock under the plan. The balances are unsecured general obligations of Target and will be paid solely in cash based on plan investment performance. This amendment corrects the number of units previously reported and reflects investment earnings and losses since a prior filing.
Target Corporation executive Michael J. Fiddelke reported routine equity compensation activity. He acquired 11,250 shares of Target common stock on April 7, 2026 at a stated price of $0.00 per share, reflecting the settlement of a performance share unit award under the Target Corporation 2020 Long-Term Incentive Plan.
On the same date, 5,131 shares were disposed of at $120.76 per share to satisfy the related tax withholding obligation. After these transactions, Fiddelke directly owned 124,790 shares of Target common stock. The filing reflects compensation and tax withholding mechanics rather than open-market buying or selling.